• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度细胞学家协会关于在腹水标本常规报告中报告浆液性液体细胞病理学的建议应用及恶性肿瘤风险评估

Application of the Indian Academy of Cytologists Recommendations for Reporting Serous Fluid Cytopathology in Routine Reporting of Ascitic Fluid Specimen and Assessment of the Risk of Malignancy.

作者信息

Jha Shilpy, Sethy Madhusmita, Adhya Amit Kumar

机构信息

Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

出版信息

J Cytol. 2022 Apr-Jun;39(2):72-77. doi: 10.4103/joc.joc_88_21. Epub 2022 May 30.

DOI:10.4103/joc.joc_88_21
PMID:35814873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9262004/
Abstract

BACKGROUND

A five-tiered reporting system for effusion fluid cytology has been published by the Indian Academy of Cytologists (IAC). Only a single study has evaluated the applicability of this system in routine reporting.

AIMS

We intend to evaluate the practical utility of this system in routine reporting of ascitic fluid cytology.

MATERIALS AND METHODS

Nine hundred and sixty-one cases of ascitic fluid cytology were included in this study. The clinical, radiological, cytomorphological, and follow-up data of these cases were reviewed. All cases were recategorized according to the proposed IAC system, and the risk of malignancy (ROM) for each category was estimated.

RESULTS

Age of the patients ranged from 1 to 92 years, and fluid volume ranged from 10 ml to 3 l. The number of cases included in each category and their respective ROM were as follows: category 1: 41, 21.42%; category 2: 805, 14.9%; category 3: 5, 33.3%; category 4: 31, 90%; and category 5:79, 96.4%.

CONCLUSIONS

The new IAC guidelines for the serous fluid is representative, informative, and could be easily applied at our institutional level. We used the recommended diagnostic categories for reclassifying the ascitic fluid samples based on their cytosmear findings and conclude that the system has enormous utility at each level starting from the collection of fluid samples till the delivery of the report.

摘要

背景

印度细胞学家学会(IAC)发布了一种用于积液细胞学的五级报告系统。仅有一项研究评估了该系统在常规报告中的适用性。

目的

我们旨在评估该系统在腹水细胞学常规报告中的实际效用。

材料与方法

本研究纳入了961例腹水细胞学病例。对这些病例的临床、放射学、细胞形态学及随访数据进行了回顾。所有病例均根据IAC提议的系统重新分类,并估算了每个类别的恶性风险(ROM)。

结果

患者年龄范围为1至92岁,腹水量范围为10毫升至3升。每个类别纳入的病例数及其各自的ROM如下:第1类:41例,21.42%;第2类:805例,14.9%;第3类:5例,33.3%;第4类:31例,90%;第5类:79例,96.4%。

结论

新的IAC浆液性液体指南具有代表性、信息丰富,且可在我们机构层面轻松应用。我们使用推荐的诊断类别,根据腹水涂片结果对腹水样本进行重新分类,并得出结论,该系统从液体样本采集到报告出具的每个环节都具有巨大效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/853b1f0b6f4b/JCytol-39-72-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/16acbe8b5eb1/JCytol-39-72-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/4515925a7420/JCytol-39-72-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/59000833e075/JCytol-39-72-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/43f1e1e788de/JCytol-39-72-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/853b1f0b6f4b/JCytol-39-72-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/16acbe8b5eb1/JCytol-39-72-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/4515925a7420/JCytol-39-72-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/59000833e075/JCytol-39-72-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/43f1e1e788de/JCytol-39-72-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7043/9262004/853b1f0b6f4b/JCytol-39-72-g005.jpg

相似文献

1
Application of the Indian Academy of Cytologists Recommendations for Reporting Serous Fluid Cytopathology in Routine Reporting of Ascitic Fluid Specimen and Assessment of the Risk of Malignancy.印度细胞学家协会关于在腹水标本常规报告中报告浆液性液体细胞病理学的建议应用及恶性肿瘤风险评估
J Cytol. 2022 Apr-Jun;39(2):72-77. doi: 10.4103/joc.joc_88_21. Epub 2022 May 30.
2
Application of Indian Academy of Cytologists Guidelines for Reporting Serous Effusions: An Institutional Experience.印度细胞学家学会关于浆液性积液报告指南的应用:一项机构经验
J Cytol. 2021 Jan-Mar;38(1):1-7. doi: 10.4103/JOC.JOC_224_20. Epub 2021 Feb 17.
3
Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.国际浆液性液体细胞病理学报告系统在各种体液报告中的应用;一家三级医院的经验。
Cytojournal. 2022 Sep 5;19:52. doi: 10.25259/Cytojournal_49_2021. eCollection 2022.
4
The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.国际浆液性液体细胞病理学报告系统:关于其在积液细胞学中恶性风险评估及意义的机构经验
J Cytol. 2023 Oct-Dec;40(4):159-164. doi: 10.4103/joc.joc_111_22. Epub 2023 Oct 16.
5
A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.回顾性分析新提出的国际浆膜腔液细胞病理学报告系统在浆膜腔积液标本中的应用:机构经验。
Acta Cytol. 2023;67(1):70-79. doi: 10.1159/000527398. Epub 2022 Dec 7.
6
Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.国际浆膜腔液细胞病理学报告系统在胸腔积液常规报告中的应用及恶性肿瘤风险评估。
Diagn Cytopathol. 2021 Oct;49(10):1089-1098. doi: 10.1002/dc.24837. Epub 2021 Jul 21.
7
Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.国际浆膜腔液细胞学报告系统(ISRSFC)在积液标本中的应用——一项肿瘤学环境中的前瞻性研究。
J Am Soc Cytopathol. 2023 Sep-Oct;12(5):351-361. doi: 10.1016/j.jasc.2023.04.005. Epub 2023 May 3.
8
Breast Fine Needle Aspiration Biopsy Cytology Using the Newly Proposed IAC Yokohama System for Reporting Breast Cytopathology: The Experience of a Single Institution.采用新提议的国际抗癌联盟(IAC)横滨乳腺细胞病理学报告系统的乳腺细针穿刺活检细胞学:单机构经验
Acta Cytol. 2019 Feb 15:1-6. doi: 10.1159/000492638.
9
Risk Stratification of Breast Fine-Needle Aspiration Biopsy Specimens Performed without Radiologic Guidance by Application of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Cytopathology.国际细胞学会横滨系统在无放射影像学引导下进行乳腺细针穿刺活检标本的风险分层报告在乳腺细针穿刺细胞学中的应用。
Acta Cytol. 2021;65(6):483-493. doi: 10.1159/000518790. Epub 2021 Sep 14.
10
Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".辅助技术在浆液性液体细胞学报告中的作用——“重新定义类别,优化诊断”
J Cytol. 2024 Apr-Jun;41(2):96-104. doi: 10.4103/joc.joc_114_23. Epub 2024 Apr 24.

引用本文的文献

1
Application of the Indian Academy of Cytologists' Recommendations for Reporting Serous Fluid Cytology.
Cureus. 2025 Apr 6;17(4):e81787. doi: 10.7759/cureus.81787. eCollection 2025 Apr.

本文引用的文献

1
Application of Indian Academy of Cytologists Guidelines for Reporting Serous Effusions: An Institutional Experience.印度细胞学家学会关于浆液性积液报告指南的应用:一项机构经验
J Cytol. 2021 Jan-Mar;38(1):1-7. doi: 10.4103/JOC.JOC_224_20. Epub 2021 Feb 17.
2
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.国际浆膜液细胞病理学报告系统(ISRSFC)在心包积液细胞学报告中的应用。
Acta Cytol. 2020;64(5):477-485. doi: 10.1159/000507311. Epub 2020 May 18.
3
Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
浆膜腔积液的细胞组织学相关性应用新提出的国际浆膜腔液细胞病理学报告系统:肿瘤中心的经验。
Diagn Cytopathol. 2021 May;49(5):596-605. doi: 10.1002/dc.24440. Epub 2020 Apr 27.
4
Indian Academy of Cytologists Guidelines for Collection, Preparation, Interpretation, and Reporting of Serous Effusion Fluid Samples.印度细胞学家学会关于浆液性积液样本采集、制备、解读及报告的指南
J Cytol. 2020 Jan-Mar;37(1):1-11. doi: 10.4103/JOC.JOC_157_19. Epub 2019 Dec 23.
5
Announcement: The International System for Reporting Serous Fluid Cytopathology.公告:浆液性液体细胞病理学报告国际系统
Acta Cytol. 2019;63(5):349-351. doi: 10.1159/000501536. Epub 2019 Jun 24.
6
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.为确保胸腔积液充分引流,需要的最小液体量为 75 毫升:2540 例回顾性分析。
Cancer Cytopathol. 2014 Sep;122(9):657-65. doi: 10.1002/cncy.21452. Epub 2014 Jul 24.
7
Prospective study to determine the volume of pleural fluid required to diagnose malignancy.前瞻性研究以确定诊断恶性肿瘤所需的胸腔积液量。
Chest. 2010 Jan;137(1):68-73. doi: 10.1378/chest.09-0641. Epub 2009 Sep 9.
8
A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
Chest. 2009 Apr;135(4):999-1001. doi: 10.1378/chest.08-2002. Epub 2008 Nov 18.
9
Volume of pleural fluid required for diagnosis of pleural malignancy.诊断胸膜恶性肿瘤所需的胸腔积液量。
Chest. 2002 Dec;122(6):1913-7. doi: 10.1378/chest.122.6.1913.
10
The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.血清腹水白蛋白梯度在腹水的鉴别诊断中优于渗出液-漏出液概念。
Ann Intern Med. 1992 Aug 1;117(3):215-20. doi: 10.7326/0003-4819-117-3-215.